D-0141-2024 Class II
Recall Details
- Product Type
- Drugs
- Report Date
- December 13, 2023
- Initiation Date
- November 22, 2023
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 825 syringes
Product Description
ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Pharma, NDC 73702-131-10
Reason for Recall
Lack of assurance of sterility.
Distribution Pattern
Philadelphia, Pennsylvania.
Code Information
Lot # 11092313110#01, Exp 01/12/24